Skip to main content
. 2021 Sep 29;65(5):617–624. doi: 10.20945/2359-3997000000399

Table 5. Comparison of the data of patients receiving testosterone and human chorionic gonadotropin therapy.

Testosterone treatment (n: 19) hCG treatment (n: 17) P
Δ Total testosterone (ng/dL) 345.7 ± 136.0 400.5 ± 151.7 0.264 b
Δ Estradiol (pg/mL) * -1 [2] 20 [2] <0.001 a
Morning erections (≥3/week), (n, %) * 10 [52.6%] 6 [35.3%] 0.478 c
Δ Total testosterone to estradiol ratio 9.4 ± 5.8 8.9 ± 4.4 0.063 b
Δ Left Mean testicular volume (mL) * 0 [0.3] 1.2 [1.5] <0.001 a
Δ Right Mean testicular volume (mL) * 0 [0.4] 1.3 [1.5] <0.001 a

hCG: human chorionic gonadotropin.

a

Mann-Whitney U test.

b

Independent t-test.

c

Yates (Continuity Correction) χ 2 test.

*

Data are presented as median (interquartile range [IQR]).

Data are presented as mean ± Standard deviation (SD).

hCG: human chorionic gonadotropin; T level: total testosterone level.